📰 Michael Weickert News

Michael Weickert News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Michael Weickert. Real-time updates on events, politics, business and more.

Pacylex CEO reveals Zelenirstat phase one results

April 22, 2024

Pacylex Pharmaceuticals Inc. has announced the presentation of phase 1 safety and efficacy findings for small molecule drug zelenirstat for cancer treatment.

United States Michael Weickert Pacylex Pharmaceuticals World Orphan Drug Congress United States Stable Disease Myeloid Leukemia

Source: outsourcing-pharma.com

Pacylex to Meet with Investors at Bio CEO Conference (BCIC) in New

February 23, 2024

Edmonton, Alberta--(Newsfile Corp. - February 23, 2024) - Pacylex Pharmaceuticals, a biotechnology company dedicated to developing

San Francisco United States Michael Weickert Newsfile Corp Pacylex Pharmaceuticals

Source: thewhig.com

Pacylex Pharmaceuticals: Develops A New Angle On Cancer Treatment Through Virtual Teamwork

December 1, 2022

Cancer is one of the leading causes of death worldwide, and it is estimated that 1 in 2 men and 1 in 3 women in the US will develop a version of this disease during their lifetime.

United States United Kingdom Michael Weickert John Mackey University Of Alberta Davos Pharmaceuticals

Source: ibtimes.com

Pathos Communications: Pacylex Pharmaceuticals Announces Progress on Early Phase Clinical Trials of PCLX-001 in Patients

September 29, 2022

Edmonton, Alberta--(Newsfile Corp. - September 29, 2022) - Pacylex Pharmaceuticals has dosed 16 patients in the early phase clinical trials of the company's new cancer drug, PCLX-001. PCLX-001 is an N-myristoyltransferase

United States British Columbia Michael Weickert Kostenloser Wertpapierhandel Michaelj Weickert Breast Cancer Research

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation